Researchers identify protein that could prevent tumor growth in cervical cancer

May 31, 2016 by Reggie Kumar
Cervical cancer cells. The disease is the second most common cause of cancer-related deaths in women. Credit: Molecular and Cellular Biology

UCLA scientists have identified a protein that has the potential to prevent the growth of cervical cancer cells. The discovery could lead to the development of new treatments for the deadly disease.

In a five-year study using human samples and mouse models, researchers led by Dr. Eri Srivatsan, a member of the UCLA Jonsson Comprehensive Cancer Center, found that a known as cystatin E/M can inhibit cellular inflammation, which is a major contributor to the growth of .

Typically, inflammation develops after a woman contracts the from a male partner; the virus can eventually lead to the development of cervical cancer. Environmental factors such as smoking also are closely associated with the disease.

The UCLA researchers discovered that cystatin E/M prevents a protein called NFkB, which regulates inflammation, from entering the nucleus of cervical cancer cells. As a result, decreased inflammation slows tumor cell growth.

"When key inhibitory mechanisms break down, produce inflammation that helps fuel ," said Srivatsan, who is a professor in UCLA's department of surgery. "By identifying this protein, we have discovered a key regulator of this breakdown. This is the first time we have found that inhibition of the protein kinase by cystatin E/M plays a regulatory role in cell ."

The study is published online in the journal Molecular and Cellular Biology.

Worldwide, cervical cancer is the second most common cause of cancer-related deaths in women. In the United States, HPV is detected in 90 percent of cervical cancer tumors and is the most common sexually transmitted disease, Srivatsan said.

Although cystatin E/M and its basic function had previously been identified, little else was known about the protein's molecular activity until 2008, when Srivatsan and colleagues' initial findings were published in Genes Chromosomes and Cancer.

The new study built upon that research. Srivatsan's team analyzed 20,000 genes in two sets of cell lines—one set that expressed the cystatin E/M protein and the other that didn't. They also analyzed 66 samples of normal and cancerous cervical tissues to determine the molecular mechanism that inhibits cancer cell growth.

In future research, Srivatsan's team will aim to determine whether cystatin E/M could inhibit tumor cell growth in chemo-radiation–resistant breast cancers in human tissue culture and animal models.

Explore further: Discovery could lead to better head and neck cancer therapies

More information: Mysore S. Veena et al. Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer, Genes, Chromosomes and Cancer (2008). DOI: 10.1002/gcc.20576

Hendrick Soh et al. Cystatin E/M suppresses tumor cell growth through cytoplasmic retention of NF-κB, Molecular and Cellular Biology (2016). DOI: 10.1128/MCB.00878-15

Related Stories

Discovery could lead to better head and neck cancer therapies

November 10, 2014

UCLA scientists have discovered that a protein usually linked to rare neurological disorders is also associated with head and neck cancer in people who are infected with the human papilloma virus. And when that protein is ...

Discovery contributes to future treatment of cervical cancer

December 4, 2015

A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has uncovered new molecular interactions involved in the development of cervical cancer. Proteins ...

Targeted treatment for liver cancer underway

May 24, 2016

Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.